Answered from 22 years of commercial experience, not generic frameworks. Every answer tells you what the constraint actually is and what to fix first.
The right time to hire a VP Sales is after your commercial motion is documented, repeatable, and capable of producing consistent results without the founder personally in the room.
If the founder is still closing more than 50% of deals, or if there is no written process that a new hire could follow to replicate a closed deal, the company is not ready. A VP Sales hired into an undocumented motion almost always fails, not because the hire was wrong, but because they were hired before there was anything to hand over. The typical cost is $150,000 to $400,000 before the business discovers this.
The test: could someone new read what exists and close a deal without asking the founder for guidance? If not, the motion is not ready for a VP.
Before hiring a first sales rep, three conditions need to be true: you have at least one committed customer who is genuinely using the product (not just trialling it), you can describe specifically which type of company buys and why they bought when they did, and you have produced at least one deal from outreach to a stranger rather than a personal connection.
A sales rep is an execution resource. Execution requires a proven motion to execute. Without those three conditions, a first sales hire will spend their time figuring out what the founder never figured out, at their cost, not the founder's.
Your ICP is likely wrong if deals close inconsistently, your pipeline looks active but conversion is low, the founder is required to close most deals, or your messaging requires explanation rather than immediate recognition.
The clearest test: compare your stated ICP against your actual closed-won profile. If the companies that actually bought are systematically different from the companies you are targeting, the ICP is wrong. The constraint is usually not that the ICP was never defined. It is that it was defined once, early, and never updated against what the data actually shows.
Pipeline that fails to convert almost always traces to one of three root causes: wrong companies entering the pipeline (ICP or targeting problem), right companies at the wrong moment (no trigger event creating urgency), or a motion that requires the founder to convert deals that would not close without them (founder dependency).
Each has a different fix. The stage at which deals stall is the most reliable indicator: deals going quiet after the first call suggest a targeting problem. Deals dying at proposal suggest a pricing or authority problem. Deals requiring founder involvement to close suggest the motion is not yet transferable.
The most reliable test: what happens when the founder is in the room versus when they are not? If deals close when the founder explains the product but fail when someone else does, the constraint is in the commercial motion, not the product.
A second test: if existing customers are getting genuine value and renewing or expanding, but new customer acquisition is difficult, the constraint is almost always GTM. If existing customers are not renewing, the constraint is more likely product or fit. Investing in a new sales motion on top of a retention problem does not fix the retention problem.
A go-to-market motion is ready to scale when it produces consistent results without the founder running every deal, when the process from first contact to signed contract is documented and teachable, and when the customer type that closes predictably is the primary target of outreach.
If any of these three conditions are unmet, scaling adds cost to an unresolved constraint. The most reliable test: could someone new read what exists and replicate a closed deal without asking the founder? If not, the motion is not ready to scale.
Revenue that stalls despite active sales activity is almost always a signal that activity is being directed at the wrong constraint. The most common patterns: outbound targeting the right company type but reaching them at the wrong moment, a sales motion that works only when the founder is involved, revenue growing from new logos while existing customers quietly contract, or high-activity segments with low conversion while high-conversion segments are under-resourced.
The activity is real. The constraint is in where it is being directed.
A company is commercially ready for a new market when the motion in the existing market is documented, repeatable, and producing consistent results without the founder closing every deal. A market entry before these conditions exist runs the same GTM discovery process twice, in two markets simultaneously, at twice the cost.
Additional checks: does the ICP transfer to the new market, or does the buyer role, trigger event, and competitive set require rebuilding? Will the reference accounts that work with home market buyers be legible to a new market buyer with no context for those names?
Founder dependency is the constraint that exists when the sales motion only works because the founder is personally involved. It is measured by the percentage of closed deals that required the founder present at the final stage. Above 70–80% is a flag at growth stage. Near 100% after ten or more closed deals means the motion is entirely non-transferable.
It matters for two reasons: it creates a ceiling on commercial capacity that no hire can raise until the motion is documented, and it appears as a due diligence flag at Series A, where investors assess whether the commercial motion can absorb the capital they are considering deploying.
Investors will examine revenue quality (separating recurring from one-time), customer concentration (percentage of ARR in the top three to five accounts), net revenue retention by cohort, forecast accuracy across the most recent three to four quarters, gross margin relative to category benchmarks, and founder dependency.
These numbers tell a different story than the pitch deck, and every gap an investor finds becomes a negotiating point they control. Identifying them before entering the process gives founders the ability to address what can be addressed and to control the narrative around what cannot.
Before entering a fundraising process, know exactly what the commercial data shows: the revenue concentration number, forecast accuracy across recent quarters, net revenue retention, gross margin, and founder dependency percentage. The gaps that can be addressed before the process begins should be. The ones that cannot need a proactive disclosure narrative the founder controls.
Every gap an investor finds during diligence becomes leverage they hold. Every gap the founder finds first is leverage they keep. The raise process becomes a series of conversations the founder controls rather than discoveries they react to.
Revenue concentration risk is the commercial exposure created when a significant percentage of ARR sits in a small number of accounts. The threshold most Series A investors treat as material is when the top three accounts represent more than 40% of ARR. Above that level, the loss of one account has a company-level financial impact, and investors price this risk into valuation or build structural conditions into term sheets to address it.
A company that identifies this before entering the fundraising process can either diversify revenue, build a plan that demonstrates concentration is reducing, or prepare a clear narrative for it. A company that discovers it mid-diligence has none of those options.
Expansion revenue requires three conditions: customers must have reached genuine value before the expansion conversation begins, a specific signal must trigger that conversation at the right moment, and someone must own it on a defined cadence. Most companies at growth stage have renewals but not expansion.
The first question is whether low expansion is a product adoption problem (customers have not fully used what they bought) or a commercial motion problem (customers have achieved value but no process exists to capture the upgrade). Each requires a different fix, and doing them in the wrong order wastes the quarter.
Most programmes assess investment readiness through mentor impressions and pitch quality, both of which are unreliable proxies for commercial readiness. A founder who pitches confidently may have an undefined ICP, no repeatable motion, and revenue entirely dependent on their personal network.
A structured commercial assessment looks at different signals: whether the ICP is specific enough to drive consistent outreach, whether the motion produces results without the founder, whether early revenue is concentrated in a handful of relationships, and whether the business is operationally ready for the pressure of a funded commercial push. Investment readiness is a commercial condition, not a presentation skill.
Individual mentor sessions give a programme one company's view at a time. A portfolio intelligence brief gives the programme a view of the whole cohort simultaneously, revealing which constraint types appear most frequently so that a single structured session addresses what would otherwise require eight separate conversations.
It also shows which founders are genuinely investment-ready versus which are 30, 60, or 90 days from readiness given specific interventions, and where mentor time creates the most aggregate impact rather than distributing it evenly across companies with very different needs.
Mentor time should be allocated based on which companies have a specific, addressable commercial constraint that experienced mentorship can resolve, not on which companies are most vocal or most polished in programme sessions. The two are often not the same.
The highest-leverage use of mentor time is typically where the same constraint appears across multiple founders simultaneously: a single session addressing a shared pattern (ICP ambiguity, founder dependency, positioning weakness) across three or four companies is more efficient than four separate conversations that each reinvent the same assessment. This is only visible with a cross-cohort view.
The commercial risks most often missed in pre-investment diligence are the ones that do not appear in the pitch deck or the financial model: the degree to which closed revenue depended on the founder personally, whether the customers in the reference list represent genuinely independent buyers or a concentrated network, whether the commercial motion is actually documented or exists only in the founder's head, and whether the growth rate reflects a repeatable process or a handful of one-time deals that will not recur.
These risks do not surface until 6 to 12 months post-investment, when the capital is deployed and the motion that looked scalable turns out to have been founder-dependent all along.
Every Wiremap assessment answers the specific commercial question you are facing right now, built from your business, not a generic framework.
Find My Report →